Navigation Links
Newly Re-launched Website Helps PhDs and MDs Capitalize on Growth in Life Science Industries
Date:9/22/2010

SANTA CRUZ, Calif., Sept. 22 /PRNewswire/ -- This month, Bio Careers (www.biocareers.com), formerly Bio Career Center, unveils its newly enhanced website. The updated online platform includes the largest U.S. job board for postgraduates in the life sciences, and an extensive archive of articles and professional development resources.

"While life science employers have not been spared by the recession, we've seen significant job growth," said Nick Folger, founder and president. "Our newly designed site helps candidates capitalize on this growth by offering them high-quality job leads and a wealth of information to help them compete in a competitive market. We're also providing an invaluable service to recruiting offices and university career centers, many of which are stretched thin."

With a founding membership among the nation's most prestigious universities, Bio Careers is the only career service dedicated to expanding professional options for life science PhDs and MDs. The website is partnered with 32 training institutions, and leverages relationships with leading employers to give degree candidates and mid-career level alumni access to high-quality job opportunities. The site's extensive network of life sciences employers include National Institutes of Health (NIH), Food and Drug Administration (FDA), Genentech, LEK Consulting, Mayo Clinic, SAIC-Frederick, PLoS and colleges and universities across the United States.

In addition to the website's robust job search engine, Bio Careers offers industry news, professional development articles, a bookstore and access to self-assessment tests and career tools. Resources cover a variety of topics including launching a new career in science policy, entrepreneurship, biopharma business, venture capital and mid-career growth.

Bio Careers' re-launch includes a life science industries blog, multimedia and social media features and functionality and online career assistance. For more information and to view the life sciences job board and article and resources database, visit www.biocareers.com.

About Bio CareersBio Careers is the first and only career service dedicated to expanding professional options for life science PhDs and MDs. The service provides online career resources and job postings to postgraduate and alumni candidates, and recruitment services to employers. Visit www.biocareers.com for more information. For more information, contact: Ty Mays, Media Relations(877) 862-4656 x.112 / ty@biocareers.com
'/>"/>

SOURCE Bio Careers
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
4. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Newly Approved HIV Drug Shows Great Promise
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
9. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):